BIM
OCAT

BlackRock Investment Management’s OCATA THERAPEUTICS, INC. COMMON STOCK OCAT Stock Holding History

BlackRock Investment Management’s Portfolio OCAT Stock Details OCAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-145,112
Closed -$1.22M – 4163
2015
Q4 		$1.22M Buy
145,112
+1,754
+1% +$11.7K ﹤0.01% 2448
2015
Q3 		$599K Buy
143,358
+21,907
+18% +$95.7K ﹤0.01% 2941
2015
Q2 		$640K Buy
+121,451
New +$778K ﹤0.01% 3041

BlackRock Investment Management's OCAT Position: Q1 2016 in Review

BlackRock Investment Management sold out of OCATA THERAPEUTICS, INC. COMMON STOCK (OCAT) in Q1 2016, closing a stake of 145,112 shares — an estimated $1.22M sold.

BlackRock Investment Management first reported a position in OCAT in Q2 2015 and held it in 3 quarters. The position peaked at $1.22M in Q4 2015. 1 fund tracked by Wall St. Rank holds OCAT as of Q1 2016.

  • BlackRock Investment Management reported no remaining OCATA THERAPEUTICS, INC. COMMON STOCK position as of Q1 2016 after selling out during the quarter.
  • BlackRock Investment Management sold 145,112 OCATA THERAPEUTICS, INC. COMMON STOCK shares in Q1 2016, an estimated $1.22M.
  • BlackRock Investment Management first reported a position in OCATA THERAPEUTICS, INC. COMMON STOCK in Q2 2015 and held it in 3 quarters.
  • BlackRock Investment Management's OCATA THERAPEUTICS, INC. COMMON STOCK position peaked at $1.22M in Q4 2015.
  • 1 fund tracked by Wall St. Rank held OCATA THERAPEUTICS, INC. COMMON STOCK as of Q1 2016.

Based on BlackRock Investment Management's 13F filing for Q1 2016, filed 10 May 2016.